20 Mar 2019 at 20:00
15 Mar 2019
Asia Pacific is the world’s 3rd largest pharma market, and it’s changing. Asia is becoming a clinical trials destination, a hotbed of biotech innovation and a place where world-class breakthrough therapies are being developed.
So in 2018, we changed too. We took ten years of expertise bringing together Asia’s biopharma and biotech players and channeled it into a brand new event focusing on the exciting future potential of Asia’s pharma and biopharma industry.
Welcome to Phar-East.
Returning in 2019 after a successful 2018 debut, Phar-East will once again bring together experts from Asian pharma & biotechs, big pharma, regulators, payers, technology innovators and more to share their expertise and chart Asia’s path forward.
Across 2 days, we’ll be exploring 4 of the most exciting areas of Asian pharma:
- Market access
- Regulatory affairs
- Pharma 4.0
PLUS! Brand new for 2019, we’ll also be adding a Clinical Trials and Biotech Investment track, giving you insights into this rapidly growing market.
Phar-East is the premier meeting place for senior executives from Asia’s pharma and biotech industry. If you want to identify opportunities in Asia for your business, you need to join us.
More information and registrations here (10% discount for French Chamber members)